Compare Eli Lilly And Co (LLY) vs Pinterest Inc (PINS) Price & Performance

Eli Lilly (LLY) trades at $1,150.86, down 2.39% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $8.55 exceeding expectations by 23%. Revenue surged to $65.18 billion in 2025, driving a net income margin of 34.99%. Recent news highlights LLY's $2.8 billion acquisition of AtaiBeckley to expand its neuroscience pipeline, signaling strategic growth in mental health treatments.

Outlook remains positive with analyst consensus price target of $1,380 implying 20% upside, supported by 73% buy ratings. Key risks include high valuation multiples (P/E 41.89) and rising debt levels, though operating cash flow growth to $16.81 billion in 2025 provides financial flexibility. Investors should monitor Q2 2026 earnings on August 5 for continued execution on weight-loss drug demand and integration of recent acquisitions.

Pinterest (PINS) trades at $22.98, down 0.95% on the day, with technical indicators showing a bullish trend supported by moving averages. The company reported strong revenue growth, reaching $4.22B in 2025 with improving profitability margins. Recent news highlights director stock sales and upcoming Q2 2026 earnings, while analyst consensus remains positive with a $27.53 price target.

PINS presents a growth opportunity with solid fundamentals and bullish technicals, though risks include competitive pressures and insider selling. The stock trades below analyst targets, offering potential upside if earnings momentum continues. Key catalysts include Q2 results and e-commerce integration progress.